Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; Parvysmelanotide (VLRX001), which provoke prolonged cellular activity; and PRÉNUMBRA, a liquid injectable formulation of afamelanotide. The company was founded in 1987 and is headquartered in Melbourne, Australia.
| Market Capitalization | $736.214 million |
| P/E Ratio | 24.98 |
| P/E Growth Ratio | 0 |
| Book Value | 3.332 |
| Dividend Per Share | 0.05 |
| Earnings Per Share | 0.59 |
| EBITDA | 44,523.576 |
| Profit Margin | 0.3908 |
| Operating Margin TTM | 0.5634 |
| Return on Assets TTM | 0.1633 |
| Return on Equity TTM | 0.2109 |
| Revenue TTM | 78,321.32 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2000-06-30 | 140 | 176 | ||
| 2001-06-30 | 409 | 71 | 1,966.279 | |
| 2002-06-30 | 258 | 81 | 4,184.754 | |
| 2003-06-30 | 136 | 75 | 4,907.431 | |
| 2004-06-30 | 355 | 86 | 8,735.256 | |
| 2005-06-30 | 124.622 | 190 | 124.622 | 12,454.437 |
| 2006-06-30 | 754.846 | 114 | 754.846 | 11,656.841 |
| 2007-06-30 | 283.308 | 957.166 | 283.308 | 11,557.212 |
| 2008-06-30 | 4,297 | 945.443 | -945.443 | 18,849.214 |
| 2009-06-30 | 2,905 | 916.535 | -916.535 | 18,191.848 |
| 2010-06-30 | 1,474 | 466 | 16,378.12 | |
| 2011-06-30 | 1,041.021 | 57 | 1,041.021 | 13,771.958 |
| 2012-06-30 | 722.801 | 52 | 722.801 | 11,028.933 |
| 2013-06-30 | 1,552.998 | 108 | 1,552.998 | 9,833.663 |
| 2014-06-30 | 2,200.092 | 3,257.839 | -1,057.747 | 5,272.491 |
| 2015-06-30 | 2,911.553 | 2,602.945 | 308.608 | 11,568.205 |
| 2016-06-30 | 6,211.339 | 3,734.79 | 2,476.549 | 6,660.692 |
| 2017-06-30 | 16,720.142 | 4,052.934 | 12,667.208 | 5,966.568 |
| 2018-06-30 | 25,485.673 | 5,985.305 | 19,500.368 | 7,352.795 |
| 2019-06-30 | 31,047.776 | 6,871.345 | 24,176.431 | 7,699.786 |
| 2020-06-30 | 32,565.423 | 9,629.843 | 22,935.58 | 11,545.098 |
| 2021-06-30 | 47,975.583 | 4,720.305 | 43,255.278 | 15,030.851 |
| 2022-06-30 | 65,722.292 | 10,483.808 | 55,238.484 | 19,908.435 |
| 2023-06-30 | 78,321.318 | 8,789.521 | 69,531.797 | 25,429.299 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2000-06-30 | 7,927.203 | 15,441.036 | 123.539 | 15,691.647 | ||
| 2001-06-30 | 6,980.55 | 13,769.023 | 318.265 | 15,382.49 | ||
| 2002-06-30 | 4,414.1 | 10,520.362 | 210.828 | 15,382.49 | ||
| 2003-06-30 | 2,611.853 | 8,066.166 | 535.451 | 16,580.441 | ||
| 2004-06-30 | 5,480.367 | 10,246.943 | 1,392.442 | 25,493.957 | ||
| 2005-06-30 | 4,762.62 | 10,055.643 | 2,601.381 | 35,122.749 | ||
| 2006-06-30 | 8,605.814 | 17,070.859 | 3,082.027 | 2,024 | 52,726.007 | |
| 2007-06-30 | 33,841.849 | 67,824.745 | 2,432.929 | 28,511.65 | 112,813.47 | |
| 2008-06-30 | 25,752.193 | 54,970.758 | 3,156.242 | 25,048.387 | 113,222.456 | |
| 2009-06-30 | 21,710.643 | 41,613.762 | 4,562.578 | 16,043.498 | 113,221.065 | |
| 2010-06-30 | 19,414.846 | 29,506.783 | 3,080.62 | 7,588.331 | 113,227.565 | |
| 2011-06-30 | 12,178.03 | 20,165.457 | 3,757.356 | 5,321.057 | 113,338.94 | |
| 2012-06-30 | 12,719.025 | 15,995.277 | 2,357.941 | 453.598 | 119,323.391 | |
| 2013-06-30 | 12,568.839 | 15,814.791 | 1,975.501 | 126,710.267 | ||
| 2014-06-30 | 14,625.583 | 17,153.568 | 1,725.836 | 133,567.056 | ||
| 2015-06-30 | 10,572.295 | 13,643.875 | 2,438.584 | 138,465.335 | ||
| 2016-06-30 | 13,844.703 | 20,138.267 | 2,303.747 | 146,764.5 | ||
| 2017-06-30 | 23,752.312 | 28,606.964 | 3,162.939 | 0 | 148,413.095 | |
| 2018-06-30 | 36,198.451 | 42,904.617 | 3,488.629 | 0 | 148,614.908 | |
| 2019-06-30 | 54,268.758 | 62,345.372 | 5,165.519 | 261.251 | 151,314.175 | |
| 2020-06-30 | 66,746.521 | 81,541.845 | 7,873.298 | 212.331 | 151,849.375 | |
| 2021-06-30 | 82,690.982 | 108,567.574 | 9,830.14 | 258.236 | 151,849.375 | |
| 2022-06-30 | 121,509.282 | 143,949.537 | 18,390.494 | 315.068 | 151,849.375 | |
| 2023-06-30 | 156,813.537 | 193,713.556 | 29,082.413 | 300.843 | 151,849.375 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2000-06-30 | 6,568.726 | |||||
| 2001-06-30 | -1,557.582 | -514.539 | 411.824 | 6,568.726 | 6,980.55 | |
| 2002-06-30 | -3,141.224 | -2,490.163 | -2,566.45 | 6,980.55 | 4,414.1 | |
| 2003-06-30 | -3,976.77 | -1,802.247 | 4,414.1 | 2,611.853 | ||
| 2004-06-30 | -6,002.501 | 2,868.514 | 2,611.853 | 5,480.367 | ||
| 2005-06-30 | -11,029.031 | -9,246.356 | -717.747 | 5,480.367 | 4,762.62 | |
| 2006-06-30 | -10,768.981 | -11,403.457 | 3,843.194 | 4,762.62 | 8,605.814 | |
| 2007-06-30 | -9,176.123 | -8,178.814 | 25,236.035 | 8,605.814 | 33,841.849 | |
| 2008-06-30 | -14,655.791 | -7,181.333 | -8,089.656 | 33,841.849 | 25,752.193 | |
| 2009-06-30 | -15,372.907 | -10,985.544 | -4,041.55 | 25,752.193 | 21,710.643 | |
| 2010-06-30 | -11,521.04 | -11,782.745 | -2,295.797 | 21,710.643 | 19,414.846 | |
| 2011-06-30 | -11,409.089 | -9,486.857 | -7,236.816 | 19,414.846 | 12,178.03 | |
| 2012-06-30 | -9,767.228 | -10,022.681 | 540.995 | 12,178.03 | 12,719.025 | |
| 2013-06-30 | -6,802.823 | -6,892.066 | -150.186 | 12,719.025 | 12,568.839 | |
| 2014-06-30 | -5,525.889 | -4,808.685 | 2,056.744 | 12,568.839 | 14,625.583 | |
| 2015-06-30 | -10,414.376 | -4,529.812 | -4,053.288 | 14,625.583 | 10,572.295 | |
| 2016-06-30 | -3,153.718 | -5,036.933 | 3,272.408 | 10,572.295 | 13,844.703 | 0 |
| 2017-06-30 | 7,180.827 | 9,916.936 | 9,907.609 | 13,844.703 | 23,752.312 | 957.16 |
| 2018-06-30 | 13,224.185 | 11,693.333 | 12,446.139 | 23,752.312 | 36,198.451 | 957.16 |
| 2019-06-30 | 18,134.16 | 18,456.107 | 18,070.307 | 36,198.451 | 54,268.758 | 957.16 |
| 2020-06-30 | 16,646.859 | 14,188.368 | 12,477.763 | 54,268.758 | 66,746.521 | 1,224.021 |
| 2021-06-30 | 24,728.247 | 19,262.061 | 15,944.461 | 66,746.521 | 82,690.982 | 1,235.266 |
| 2022-06-30 | 20,878.465 | 21,636.291 | 38,818.3 | 82,690.982 | 121,509.282 | 1,235.265 |
| 2023-06-30 | 30,604.566 | 36,912.063 | 35,304.255 | 121,509.282 | 156,813.537 | 1,976.414 |